SLP Simulations Plus
- 44.690
- -0.900-1.97%
- 44.690
- 0.0000.00%
Simulations Plus News
Craig-Hallum Remains a Buy on Simulations Plus (SLP)
Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)
Craig-Hallum Maintains Buy on Simulations Plus, Raises Price Target to $51
Simulations Plus Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Immunome (IMNM) and Simulations Plus (SLP)
Craig-Hallum Reaffirms Their Buy Rating on Simulations Plus (SLP)
BTIG Remains a Buy on Simulations Plus (SLP)
BTIG Remains a Buy on Simulations Plus (SLP)
Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Celcuity (CELC)
Oppenheimer Adjusts Simulations Plus Price Target to $55 From $67, Maintains Outperform Rating
Positive Outlook on Simulations Plus' Future Growth Despite F4Q:23 Revenue Miss: An Analysis of David Larsen's Buy Rating
Positive Growth Projections and Strategic Acquisition Bolster Buy Rating for Simulations Plus: An Analysis by Francois Brisebois
Craig-Hallum Remains a Buy on Simulations Plus (SLP)
Craig-Hallum Remains a Buy on Simulations Plus (SLP)
Analysts Are Bullish on Top Healthcare Stocks: Pliant Therapeutics (PLRX), Simulations Plus (SLP)
Certara Downgraded at Jefferies on Growth Headwinds
Simulations Plus (SLP) Gets a Buy From Craig-Hallum
Oppenheimer Reiterates Outperform on Simulations Plus, Maintains $67 Price Target
Analysts' Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB) and Simulations Plus (SLP)
Analysts Are Bullish on Top Healthcare Stocks: Apyx Medical (APYX), Simulations Plus (SLP)
Analysis
Price Target
No Data
